Miniaturisation
The progressive shrinking of follicles under androgen influence, producing shorter, finer hairs each cycle until growth stops. Its extent, seen on trichoscopy, guides prognosis and treatment.
Miniaturisation is the process behind androgenetic hair loss: under androgen signalling, susceptible follicles produce a slightly shorter, finer hair with each growth cycle, growth phases contract, and terminal hairs regress step by step towards the faint vellus hairs of a child’s cheek. Baldness is the endpoint the eye notices; miniaturisation is the years of process the eye misses. Visible thinning lags the biology: because calibre does much of the visual work, a scalp can lose a large share of its hair mass before the mirror shows it.
The clinically important property is that it is a spectrum with a window. A miniaturising follicle is a smaller factory, not a dead one — which is why early pharmacological treatment can thicken existing hairs, and why much of what patients call regrowth is really re-enlargement. Left long enough, the process ends in a follicle that no longer produces meaningful hair, and late-stage change is not reliably recoverable. Timing, in other words, is most of the treatment conversation.
Trichoscopy is how miniaturisation is seen and tracked: variation in shaft diameters across a field of view — anisotrichosis — with a rising share of thin and vellus hairs is its signature, and it distinguishes pattern loss from shedding conditions in which shaft calibre stays uniform. The same measurement maps geography, revealing zones that still look covered but are already thinning, and documents whether treatment is actually changing the trajectory. Serial images at fixed reference points, months apart, turn a static impression into a measured trend worth acting on.
For surgical planning, miniaturisation is the future-projection tool. It shows how far the pattern will likely extend, whether the donor margins are as safe as they appear, and where native hair around a planned recipient zone is fragile — miniaturised hairs are the ones most vulnerable to post-operative shock loss, and the ones whose eventual departure a design must anticipate. A transplant planned only on today’s visible loss is planned for a scalp that will not exist in ten years.